Rock Springs Capital Management LP Q4 2020 Filing
Filed February 16, 2021
Portfolio Value
$4.7B
Holdings
154
Report Date
Q4 2020
Filing Type
13F-HR
All Holdings (154 positions)
| Stock | Value |
|---|---|
NBIXNEUROCRINE BIOSCIENCES INC | $151.0M |
IRTCIRHYTHM TECHNOLOGIES INC | $148.3M |
UNHUNITEDHEALTH GROUP INC | $142.0M |
HUMHUMANA INC | $116.9M |
ZLABZAI LAB LTD | $115.7M |
AGIOAGIOS PHARMACEUTICALS INC | $109.3M |
ISRGINTUITIVE SURGICAL INC | $98.2M |
2L9BLUEPRINT MEDICINES CORP | $94.4M |
AFWALIGN TECHNOLOGY INC | $87.4M |
ACADACADIA PHARMACEUTICALS INC | $86.2M |
ARGXARGENX SE | $84.6M |
MRTXEURMIRATI THERAPEUTICS INC | $82.0M |
PODDINSULET CORP | $81.3M |
RAREULTRAGENYX PHARMACEUTICAL IN | $78.4M |
NVTA1EURINVITAE CORP | $77.4M |
HCAHCA HEALTHCARE INC | $74.0M |
FRPTFRESHPET INC | $71.9M |
AVIRATEA PHARMACEUTICALS INC | $70.9M |
NVROEURNEVRO CORP | $68.4M |
EXASEXACT SCIENCES CORP | $64.3M |
ARVNARVINAS INC | $63.4M |
NVV1NOVAVAX INC | $62.8M |
IDXXIDEXX LABS INC | $62.5M |
PCRXPACIRA BIOSCIENCES INC | $61.3M |
ONCBEIGENE LTD | $58.1M |
BIIBBIOGEN INC | $56.3M |
SRPTSAREPTA THERAPEUTICS INC | $56.0M |
—MERSANA THERAPEUTICS INC | $54.9M |
TFXTELEFLEX INCORPORATED | $53.5M |
EWEDWARDS LIFESCIENCES CORP | $53.1M |
ALXNALEXION PHARMACEUTICALS INC | $47.9M |
ALLKGUSDALLAKOS INC | $47.8M |
PHRPHREESIA INC | $46.1M |
HZNPHORIZON THERAPEUTICS PUB L | $45.7M |
KYMRKYMERA THERAPEUTICS INC | $44.3M |
CNCCENTENE CORP DEL | $43.8M |
SGENUSDSEAGEN INC | $43.8M |
ALNYALNYLAM PHARMACEUTICALS INC | $43.5M |
EHCENCOMPASS HEALTH CORP | $41.3M |
IMVTIMMUNOVANT INC | $41.2M |
—EARGO INC | $40.3M |
INSPINSPIRE MED SYS INC | $40.1M |
SPRBSPRUCE BIOSCIENCES INC | $39.6M |
ASNDASCENDIS PHARMA A/S | $38.9M |
ADPTADAPTIVE BIOTECHNOLOGIES COR | $37.5M |
CVETUSDCOVETRUS INC | $36.9M |
ACHCACADIA HEALTHCARE COMPANY IN | $35.2M |
LUNGPULMONX CORP | $34.5M |
HCATHEALTH CATALYST INC | $34.2M |
ARDXARDELYX INC | $33.3M |
NKTXNKARTA INC | $33.3M |
NVCRNOVOCURE LTD | $30.3M |
—ATHIRA PHARMA INC | $29.5M |
BSXBOSTON SCIENTIFIC CORP | $28.8M |
BFAMBRIGHT HORIZONS FAM SOL IN D | $28.6M |
MDGLMADRIGAL PHARMACEUTICALS INC | $28.5M |
TVTXTRAVERE THERAPEUTICS INC | $27.8M |
PENPENUMBRA INC | $27.8M |
—EPIZYME INC | $27.7M |
MIRMMIRUM PHARMACEUTICALS INC | $26.1M |
INCYINCYTE CORP | $26.1M |
PRLDPRELUDE THERAPEUTICS INC | $25.8M |
GHGUARDANT HEALTH INC | $25.8M |
STTKSHATTUCK LABS INC | $25.6M |
TGTXTG THERAPEUTICS INC | $25.4M |
KRTXKARUNA THERAPEUTICS INC | $24.8M |
BAXBAXTER INTL INC | $24.2M |
RPRXROYALTY PHARMA PLC | $24.0M |
SPROSPERO THERAPEUTICS INC | $23.9M |
AM6AMICUS THERAPEUTICS INC | $23.8M |
OSH3EUROAK STR HEALTH INC | $22.9M |
SWAVUSDSHOCKWAVE MED INC | $22.8M |
BMRNBIOMARIN PHARMACEUTICAL INC | $22.2M |
COLLCOLLEGIUM PHARMACEUTICAL INC | $22.0M |
RCKTROCKET PHARMACEUTICALS INC | $22.0M |
ACCDEURACCOLADE INC | $21.8M |
AMRNAMARIN CORP PLC | $20.5M |
CHRSCOHERUS BIOSCIENCES INC | $20.2M |
—ABCAM PLC | $19.9M |
—PPD INC | $18.0M |
—GAMIDA CELL LTD | $17.6M |
ACRSACLARIS THERAPEUTICS INC | $17.3M |
CYTK 4 11/15/26CYTOKINETICS INC | $17.3M |
INZYINOZYME PHARMA INC | $17.1M |
RLAYRELAY THERAPEUTICS INC | $17.1M |
RIGLUSDRIGEL PHARMACEUTICALS INC | $16.6M |
KURAKURA ONCOLOGY INC | $16.6M |
CERE1EURCEREVEL THERAPEUTICS HLDNG I | $16.6M |
GLPGGALAPAGOS NV | $16.3M |
—INTERSECT ENT INC | $16.0M |
TARAPROTARA THERAPEUTICS INC | $15.6M |
RYTMRHYTHM PHARMACEUTICALS INC | $14.6M |
JAZZJAZZ PHARMACEUTICALS PLC | $14.4M |
—MYOVANT SCIENCES LTD | $14.2M |
GOSS 5 06/01/27GOSSAMER BIO INC | $14.2M |
APLTAPPLIED THERAPEUTICS INC | $14.0M |
—GW PHARMACEUTICALS PLC | $13.8M |
CGENCOMPUGEN LTD | $13.7M |
PRTAPROTHENA CORP PLC | $13.7M |
AKROAKERO THERAPEUTICS INC | $13.3M |
Page 1 of 2Next